The small intestine and nutrition: Intestinal permeation and gastrointestinal disease

Journal of Clinical Gastroenterology

Volumn 34, Issue 4, 2002, Pages 385-396

  DeMeo, Mark T ^a   Mutlu, Ece A ^a   Keshavarzian, Ali ^a   Tobin, Mary C ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Gastrointestinal disease; Gastrointestinal tract; Intestinal permeation

Indexed keywords

ALCOHOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE PANCREATITIS; ALCOHOL CONSUMPTION; CELIAC DISEASE; CONTROLLED STUDY; CROHN DISEASE; DRUG INDUCED DISEASE; DRUG USE; ENDOTOXEMIA; FOOD ALLERGY; GASTROINTESTINAL DISEASE; HUMAN; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; LIVER DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ACUTE DISEASE; DIGESTIVE SYSTEM; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; PANCREATITIS; PERMEABILITY; PH; SECRETION; STOMACH ACID;

ACUTE DISEASE; CELIAC DISEASE; CROHN DISEASE; DIGESTIVE SYSTEM; FOOD HYPERSENSITIVITY; GASTRIC ACID; HUMANS; HYDROGEN-ION CONCENTRATION; LIVER DISEASES; PANCREATITIS; PERMEABILITY;

EID: 0036202565     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200204000-00003     Document Type: Review

References (107)

1. Non-immunologic defense mechanisms of the gut
2. Immunology and inflammation of the gastrointestinal tract
3. Defensins and innate host defense of the gastrointestinal tract
4. Paneth cells and innate immunity in the crypt microenvironment
5. The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans
6. Mitochondrial damage: A possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine
7. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans
8. Cytokine regulation of epithelial permeability and ion transport
9. Nitric oxide in mucosal defense: A little goes a long way
10. iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers
11. Poly(ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells
12. Hyperpermeability of intestinal epithelial monolayers is induced by NO: Effect of low extracellular pH
13. Unsolved mysteries of intestinal M cells
14. 1990 McCollum Award lecture. Nutrition and immunity: Lessons from the past and new insights into the future
15. Intestinal permeability: An overview
16. Intestinal permeability
17. The intestinal permeability barrier: A hypothesis as to its regulation and involvement in Crohn's disease
18. Permeability of the rat small intestinal epithelium along the villus-crypt axis: Effects of glucose transport
19. Evolving concepts in the pathogenesis of postinjury multiple organ failure
20. Clinical significance of translocation
21. Role of the gut in multiple organ failure: Bacterial translocation and permeability changes
22. Multiple organ failure: Pathophysiology and potential future therapy
23. TEN versus TPN following major abdominal trauma-reduced septic morbidity
24. Role of early enteral feeding and acute starvation on postburn bacterial translocation and host defense: Prospective, randomized trials
25. Total parenteral nutrition promotes bacterial translocation from the gut
26. Bacterial translocation in multiple organ failure: Cause or epiphenomenon still unproven
27. The prevalence of gut translocation in humans
28. Microbiology of bacterial translocation in humans
29. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients
30. Interleukin 10-deficient colitis: New similarities to human inflammatory bowel disease
31. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin
32. Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon
33. Absorption of 51 -chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease
34. Assessment of the lactulose-mannitol test in Crohn's disease
35. Intestinal permeability in patients with Crohn's disease and their healthy relatives
36. Intestinal permeability and the prediction of relapse in Crohn's disease
37. Increased pulmonary and intestinal permeability in Crohn's disease
38. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk
39. Increased intestinal permeability in patients with Crohn's disease and their relatives: A possible etiologic factor
40. 51Cr-labeled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives
41. Is small intestinal permeability really increased in relatives of patients with Crohn's disease?
42. Intestinal permeability in patients with Crohn's disease and their first degree relatives
43. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives
44. Clustering of increased small intestinal permeability in families with Crohn's disease
45. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: An inherited defect in mucosal defense?
46. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease
47. CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability
48. Electrolyte transport across colonic mucosa from patients with inflammatory bowel disease
49. A freeze fracture study of Crohn's disease of the terminal ileum: Changes in epithelial tight junction organization
50. Increased permeability of macroscopically normal small bowel in Crohn's disease
51. Gastroduodenal permeability in Crohn's disease
52. Increased gastric and intestinal permeability in patients with Crohn's disease
53. Intestinal permeability test as a predictor of clinical course in Crohn's disease
54. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
55. Functional and morphologic changes in small bowel of Crohn's disease patients: Influence of site of disease
56. Gastrointestinal permeability in celiac disease
57. Cellobiose/mannitol sugar test, a sensitive tubeless test for celiac disease: Results on 1010 unselected patients
58. A simple, non-invasive marker of gastric damage: Sucrose permeability
59. Sucrose: A novel permeability marker for gastroduodenal disease
60. Abnormal permeability precedes the development of a gluten sensitive enteropathy in Irish setter dogs
61. Screening for celiac disease in first-degree relatives of patients with celiac disease by lactutose/mannitol test
62. Intestinal permeability in patients with celiac disease and relatives of patients with celiac disease
63. Studies of intestinal lymphoid tissue: XIV-HLA status, mucosal morphology, permeability and epithelial lymphocyte populations in first degree relatives of patients with celiac disease
64. Chadwick versus bacterial chemotactic oligopeptides and the intestinal mucosal barrier
65. Effect of immunologic reactions on rat intestinal epithelium: Correlation of increased permeability to chromium 51-labeled ethylenediaminetetraacetic acid and ovalbumin during acute inflammation and anaphylaxis
66. Helping the mucosa make sense of macromolecules
67. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease: SIGEP Study Group for Autoimmune Disorders in Celiac Disease
68. Macromolecular absorption of food antigens in health and disease
69. Neonatal IgA secretion enhanced by breast feeding
70. Antibodies IgG, IgA, and IgM to food antigens during the first 18 months of life in relation to feeding and development of atopic disease
71. Effect of disodiumcromoglycate on intestinal permeability changes and clinical response during cow's milk challenge
72. Food-induced alterations of intestinal permeability in children with cow's milk-sensitive enteropathy and atopic dermatitis
73. 51Cr]EDTA intestinal permeability in children with cow's milk intolerance
74. Small intestinal permeability in pediatric clinical practice
75. The impact of milk and weaning diet on gastrointestinal permeability in English and Gambian infants
76. Gastrointestinal permeability in children with cow's milk allergy: Effect of milk challenge and sodium cromoglycate as assessed with polyethyleneglycols (PEG 400 and PEG 1000)
77. Identical intestinal permeability changes in children with different clinical manifestations of cow's milk allergy
78. Mononuclear cells from infants allergic to cow's milk secrete tumor necrosis factor alpha, altering intestinal function
79. Cytokine-induced alteration of the epithelial barrier to food antigens in disease
80. Gastrointestinal permeability in food-allergic eczematous children
81. Modifications of intestinal permeability during food provocation procedures in pediatric irritable bowel syndrome
82. Intestinal permeability in irritable bowel syndrome: Effect of diet and sodium cromoglycate administration
83. Measurement of intestinal permeability to mannitol and lactulose as a means of diagnosing food allergy and evaluating therapeutic effectiveness of disodium cromoglycate
84. The intestinal permeability test applied to the diagnosis of food allergy in pediatrics
85. Intestinal permeability in patients with eczema and food allergy
86. Intestinal permeability in patients with atopic eczema
87. Intestinal permeability in patients with atopic eczema
88. 51Cr-labeled ethylenediaminetetraacetate in food-intolerant subjects
89. The role of infection in acute pancreatitis
90. Gut macromolecular permeability in pancreatitis correlates with severity of disease in rats
91. Bacterial translocation: A potential source for infection in acute pancreatitis
92. Gut origin sepsis, macrophage function, and oxygen extraction associated with acute pancreatitis in the rat
93. The effect of epidermal growth factor on the septic complications of acute pancreatitis
94. Enteral nutrition prevents bacterial translocation but does not improve survival during acute pancreatitis
95. Gut permeability in patients with acute pancreatitis
96. Differential prognosis of gram-negative versus gram-positive infected and sterile pancreatic necrosis: Results of a randomized trial in patients with severe acute pancreatitis treated with adjuvant selective decontamination
97. Selective decontamination of the digestive tract in acute severe pancreatitis: An indication whose time has come
98. Comparison of the safety of early enteral vs parenteral nutrition in mild acute pancreatitis
99. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: Results of a randomized prospective trial
100. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis
101. Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis
102. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumor necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis
103. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease)
104. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess
105. Exacerbation of alcoholic liver injury by enteral endotoxin in rats
106. Leaky gut in alcoholic cirrhosis: A possible mechanism for alcohol-induced liver damage
107. Endotoxemia, encephalopathy, and mortality in cirrhotic patients